Padma Shri | Medicine (Oncology) | Telangana
When Dr. Palkonda Vijay Anand Reddy performed India’s first perioperative brain interstitial implant, he didn’t merely introduce a new surgical technique—he eliminated the need for Indian patients to seek this complex brain tumor treatment abroad. This achievement encapsulates the dual nature of his Padma Shri recognition: technical excellence married to humanitarian purpose. His acceptance speech, dedicating the honor to patients, teachers, and Apollo Hospitals for enabling three decades of free care for children, reveals the values that have guided his distinguished career.
As Director and Senior Consultant Oncologist at Apollo Cancer Hospital, Jubilee Hills, Dr. Reddy has pioneered multiple innovations that have democratized access to advanced cancer treatment. His introduction of hypofractionated radiotherapy and short-course radiation protocols represents a significant breakthrough—maintaining treatment efficacy while dramatically reducing treatment duration. For patients, particularly those from rural areas or limited means, this innovation transforms cancer care from a prolonged ordeal requiring extended stays to a manageable intervention.
Dr. Reddy’s extensive fellowship training across continents—including stereotactic radiosurgery in Germany, ocular oncology in Philadelphia, head and neck oncology in Australia, and brachytherapy in New York—reflects his commitment to bringing global expertise to Indian patients. Yet unlike many who acquire international training, Dr. Reddy returned to establish Apollo Cancer Centres as a center of excellence with cure rates comparable to the world’s top cancer institutions. His role as founding director instrumental in this transformation demonstrates that individual clinical excellence can catalyze institutional capability.
What distinguishes Dr. Reddy’s Padma Shri is the CURE Foundation’s work, through which he has provided free cancer treatment to thousands of underprivileged children over three decades. This commitment to equitable access represents his understanding that medical excellence means nothing if limited to those who can afford it. His book “I Am a Survivor,” sharing 108 stories of cancer survivors, reveals his philosophy—that hope, empathy, and compassion are as essential as technical skill in fighting cancer.
Dr. Reddy’s leadership of Apollo’s multidisciplinary tumor board exemplifies modern cancer care’s collaborative nature. Rather than individual physicians making isolated decisions, the board brings together specialists across disciplines, ensuring comprehensive treatment planning. This institutional innovation, combined with his introduction of advanced technologies like stereotactic radiosurgery and IMRT (Intensity Modulated Radiotherapy), has elevated Indian cancer care to international standards.
The timing of this Padma Shri carries particular significance. As India confronts rising cancer incidence, Dr. Reddy’s career offers a template for addressing this challenge. His combination of technical innovation, institutional leadership, and commitment to equitable access demonstrates that world-class cancer care can be delivered in India while remaining accessible to all socioeconomic strata. The recognition celebrates not just past achievements but continuing dedication to a mission larger than individual success—transforming cancer from a death sentence to a manageable disease for every Indian, regardless of their ability to pay.
–Dr. Srinayani Kavuri
